Natixis Advisors, L.P.

SEC CIK: 0001018331
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Natixis Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q2 2026): 129,236
Value: $80.6M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of REGN by Natixis Advisors, L.P., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	129,236	$80.6M	0.1%	+3,563+2.8%	Added	Holders
Q1 2026	125,673	$97.1M	0.1%	+3,085+2.5%	Added	Holders
Q4 2025	122,588	$94.6M	0.1%	+2,479+2.1%	Added	Holders
Q3 2025	120,109	$67.5M	0.1%	+7,084+6.3%	Added	Holders
Q2 2025	113,025	$59.3M	0.1%	−3,207−2.8%	Reduced	Holders
Q1 2025	116,232	$73.7M	0.1%	+6,294+5.7%	Added	Holders
Q4 2024	109,938	$78.3M	0.1%	−7,064−6.0%	Reduced	Holders
Q3 2024	117,002	$123.0M	0.2%	+319+0.3%	Added	Holders
Q2 2024	116,683	$122.6M	0.3%	+2,720+2.4%	Added	Holders
Q1 2024	113,963	$109.7M	0.3%	+3,546+3.2%	Added	Holders
Q4 2023	110,417	$97.0M	0.3%	−604−0.5%	Reduced	Holders
Q3 2023	111,021	$91.4M	0.3%	−123−0.1%	Reduced	Holders
Q2 2023	111,144	$79.9M	0.2%	−859−0.8%	Reduced	Holders
Q1 2023	112,003	$92.0M	0.3%	+4,588+4.3%	Added	Holders
Q4 2022	107,415	$77.5M	0.3%	−27,451−20.4%	Reduced	Holders
Q3 2022	134,866	$92.9M	0.4%	−326−0.2%	Reduced	Holders
Q2 2022	135,192	$79.9M	0.4%	−40,701−23.1%	Reduced	Holders
Q1 2022	175,893	$122.8M	0.5%	−5,398−3.0%	Reduced	Holders
Q4 2021	181,291	$114.5M	0.4%	−71,561−28.3%	Reduced	Holders
Q3 2021	252,852	$153.0M	0.6%	+115,720+84.4%	Added	Holders
Q2 2021	137,132	$76.6M	0.4%	−1,206−0.9%	Reduced	Holders
Q1 2021	138,338	$65.5M	0.3%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.